Targeted CRISPR lipid nanoparticles eliminated 50% of tumors in mice with head and neck cancer.

Pioneering the World's 1st Dark Matter Cancer Immunotherapy UbiVac's DPV-001 is the World's 1st Dark Matter Cancer Immunotherapy in the Cli ...

SCI Corporation ("CEL-SCI" or the "Company") (NYSE American: CVM), a Phase 3 cancer immunotherapy company, today announced ...

Recently reported positive preliminary data from Phase 1 dose escalation trial of micvotabart pelidotin (“MICVO,” formerly PYX-201), including ...

J&J will now pick up almost the full tab for the phase 3 trial, and, in return, Nanobiotix will see the potential milestone ...

An 85-year-old who credits the Lingen Davies Cancer Centre with saving his life is preparing for a final trip to his beloved ...

Two neoadjuvant immunotherapy combinations for head and neck cancer substantially increased the response rate versus a single ...

Dr Toral Vaidya, a New York City based board certified dermatologist, recently shared signs and symptoms of skin cancer she ...

Dr Toral Vaidya, a dermatologist based in New York City, has shared the different types of skin cancer there are and the ...

High sugar-sweetened beverage intake was associated with increased oral cavity cancer in women – regardless of smoking or ...

Sitaben Purohit, the owner of the city's renowned Shree Thaker Bhojanalay, has undergone 60 surgeries over the past 25 years for oral canc.